anti-inflammatory therapies for COVID-19 - living meta-analysis of clinical studies

meta|evidence COVID-19

Living systematic review and meta-analysis

vs. potential COVID-19 treatments
vs. adjuvant therapies
vs. paracetamol
vs. antiviral and associated therapy
vs. hydroxychloroquine plus macrolides
vs. azithromycin plus hydroxychloroquine
vs. control
vs. placebo
vs. standard of care

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
root
secondary prevention

Studies
Mapping
Meta-analysis
Excluded 0

table network network 2

display ongoing demontrated benefit only

popup

COLCORONA, 2021 NCT04322682

colchicine vs. placebo

COVID 19 outpatients

PRINCIPLE (COLCHICINE), 2021 ISRCTN86534580

colchicine vs. standard of care

COVID 19 outpatients

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open